Evidence map›Paper›PMID 22307907›Full record

ReviewAmerican journal of physiology. Lung cellular and molecular physiology2012

A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Jose Gomez-Arroyo, Sheinei J Saleem, Shiro Mizuno, Aamer A Syed, Harm J Bogaard, Antonio Abbate, Laimute Taraseviciene-Stewart, Yon Sung, Donatas Kraskauskas, Daniela Farkas and 3 more

Open access · greenAbstract readReview
In one paragraph

Review in American journal of physiology. Lung cellular and molecular physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it, 201 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. LOXL2 inhibition ameliorates pulmonary artery remodeling in pulmonary hypertension.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  14. Article
  15. Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  16. Article
  17. Animals in Respiratory Research.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Pulmonary Hypertension in Women.Methodist DeBakey cardiovascular journal · 2024
    Review
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Jose Gomez-ArroyoVictoria Johnson Center for Obstructive Lung Disease Research, Virginia Commonwealth University, 1220 E. Broad St., Richmond, VA 23298, USA.
Sheinei J Saleem
Shiro Mizuno
Aamer A Syed
Harm J Bogaard
Antonio Abbate
Laimute Taraseviciene-Stewart
Yon Sung
Donatas Kraskauskas
Daniela Farkas
Daniel H Conrad
Mark R Nicolls
Norbert F Voelkel
Pulmonary and Critical Care Associates · USStanford University · USVirginia Commonwealth University · USKanazawa Medical University · JPUniversity of Denver · USVrije Universiteit Amsterdam · NL

Funding

The Cellular Response to Elafin in PAHP01HL108797 · NHLBI · STANFORD UNIVERSITY · PI NOLAN, GARRY P · 2011 to 2021
$19.7M
Critical Role for Microvasculature in Airway TransplantationR01HL095686 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · PI NICOLLS, MARK ROBERT · 2010 to 2022
$4.7M
An Autoimmune Basis for Pulmonary Hypertension.R01HL082662 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI NICOLLS, MARK ROBERT · 2006 to 2009
$1.8M
NHLBI NIH HHS P01 HL108797NHLBI NIH HHS R01 HL082662NHLBI NIH HHS R01 HL095686
6 · The paper itself

Abstract

Many chronic pulmonary diseases are associated with pulmonary hypertension (PH) and pulmonary vascular remodeling, which is a term that continues to be used to describe a wide spectrum of vascular abnormalities. Pulmonary vascular structural changes frequently increase pulmonary vascular resistance, causing PH and right heart failure. Although rat models had been standard models of PH research, in more recent years the availability of genetically engineered mice has made this species attractive for many investigators. Here we review a large amount of data derived from experimental PH reports published since 1996. These studies using wild-type and genetically designed mice illustrate the challenges and opportunities provided by these models. Hemodynamic measurements are difficult to obtain in mice, and right heart failure has not been investigated in mice. Anatomical, cellular, and genetic differences distinguish mice and rats, and pharmacogenomics may explain the degree of PH and the particular mode of pulmonary vascular adaptation and also the response of the right ventricle.

Indexed as

Disease Models, AnimalAnimalsBlood PressureFamilial Primary Pulmonary HypertensionHeart VentriclesHypertension, PulmonaryHypertrophy, Right VentricularMiceMice, TransgenicPulmonary ArteryRatsVascular ResistanceVentricular Function, RightVentricular Remodeling

Identifiers

PMID22307907
PMCPMC3774477
OpenAlexW2107763047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.